Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Pathology Informatics|July 2, 2024
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancerSushant Patkar, Stephanie Harmon, Isabell Sesterhenn, et al.Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
SPINK1 protein expression and prostate cancer progressionRichard Flavin, Andreas Pettersson, Whitney K Hendrickson, et al.Neuro-Oncology|April 5, 2013
Phase 2 study of dose-intense temozolomide in recurrent glioblastomaAndrew D Norden, Glenn J Lesser, Jan Drappatz, et al.The Journal of Urology|March 8, 2021
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate CancerRana R McKay, Wanling Xie, Huihui Ye, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.AJR. American Journal of Roentgenology|July 16, 2025
Evaluating Artificial Intelligence-Assisted Prostate Biparametric MRI Interpretation: An International Multireader StudyDavid G Gelikman, Enis C Yilmaz, Stephanie A Harmon, et al.Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.Pageof 3